Effects of the Covid-19 pandemic on the quality of life of patients with Amyotrophic Lateral Sclerosis
Abstract
Introduction: In recent months, the emergence of SARS-CoV-2 as a global pandemic has caused a devastating impact on health worldwide. Health systems have been overwhelmed, and the follow-up of those patients who require continuous monitoring and evaluation, such as Amyotrophic Lateral Sclerosis (ALS), have been negatively affected.
Material and method: A search of the current literature has been carried out to determine the impact of the Covid-19 pandemic on the quality of life of patients diagnosed with Amyotrophic Lateral Sclerosis and their family.
Results:The diagnosis, treatment, follow-up and home care of these patients have been modified, adapting them as much as possible to the technology and available resources to try to minimize the loss of quality of life of patients diagnosed with Sclerosis Amyotrophic lateral and ensuring comprehensive care.
Conclusion: Despite numerous efforts and advances in research, both in the case of ALS and COVID-19, there is still a long way to go.
Downloads
References
Cassmeyer V, Long B, Phipps W. Médico-quirúrgica. 3a. Madrid: Harcourt Brace; 1997.
Lemone P, Burke K. Enfermería médico-quirúrgica. Pensamiento crítico en la asistencia del paciente. Volumen I. 4a. Madrid: Pearson Educación; 2009. 1122.
Pinto S, Quintarelli S, Silani V. New technologies and Amyotrophic Lateral Sclerosis – Which step forward rushed by the COVID-19 pandemic? Vol. 418, Journal of the Neurological Sciences. Elsevier B.V.; 2020.
Estrategia en Enfermedades Neurodegenerativas del Sistema Nacional de Salud [Internet]. Ministerio de Sanidad, Servicios Sociales e Igualdad. 2016. p. 1–150. Available from: http://www.mscbs.gob.es/organizacion/sns/planCalidadSNS/pdf/Est_Neurodegenerativas_APROBADA_C_INTERTERRITORIAL.pdf
Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet Journal of Rare Diseases. 2009;4(1):1–22.
Bombaci A, Abbadessa G, Trojsi F, Leocani L, Bonavita S, Lavorgna L. Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail. Neurological Sciences [Internet]. 2020 Oct 6; Available from: http://link.springer.com/10.1007/s10072-020-04783-x
Steinbach R, Prell T, Gaur N, Stubendorff B, Roediger A, Ilse B, et al. Triage of Amyotrophic Lateral Sclerosis Patients during the COVID-19 Pandemic: An Application of the D50 Model. Journal of Clinical Medicine. 2020 Sep 5;9(9):2873.
Nasuello NA, Pettinaroli R, Godi L, Savoini C, de Marchi F, Mazzini L, et al. Critical illness neuro-myopathy (CINM) and focal amyotrophy in intensive care unit (ICU) patients with SARS-CoV-2_ a case series. Neurological Sciences. 2020 Oct 13;1–3.
Rajabally YA, Goedee HS, Attarian S, Hartung HP. Management challenges for chronic dysimmune neuropathies during the COVID-19 pandemic. Muscle and Nerve. 2020 Jul 1;62(1):34–40.
Solé G, Salort-Campana E, Pereon Y, Stojkovic T, Wahbi K, Cintas P, et al. Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network. Revue Neurologique. 2020 Jun 1;176(6):507–15.
de Marchi F, Cantello R, Ambrosini S, Mazzini L. Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19. Neurological Sciences. 2020; 41:1365–7.
Consonni M, Telesca A, Bersano E, Lauria G. Amyotrophic lateral sclerosis patients’ and caregivers’ distress and loneliness during COVID-19 lockdown. Journal of Neurology [Internet]. 2020 Jul 21 [cited 2020 Nov 2];1–4. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372539/
Andrews JA, Berry JD, Baloh RH, Carberry N, Cudkowicz ME, Dedi B, et al. Amyotrophic lateral sclerosis care and research in the United States during the COVID-19 pandemic: Challenges and opportunities. Muscle and Nerve. 2020 Aug 1;62(2):182–6.
de Almeida JPL, Pinto AC, Pereira J, Pinto S, de Carvalho M. Implementation of a wireless device for real-time telemedical assistance of home-ventilated amyotrophic lateral sclerosis patients: A feasibility study. Telemedicine and e-Health. 2010 Oct 1;16(8):883–8.
Young EI, Manta D, Sah BP, Brooks BR. Modification of non-invasive ventilation for the advanced amyotrophic lateral sclerosis patient during the COVID-19 pandemic - do it now. Vol. 414, Journal of the Neurological Sciences. Elsevier B.V.; 2020.
Andrews J. Amyotrophic Lateral Sclerosis: Clinical Management and Research Update (Jinsy Andrews). 2009; Available from: http://download.springer.com.ezproxy1.lib.asu.edu/static/pdf/930/art%253A10.1007%252Fs11910-009-0010-0.pdf?originUrl=http%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs11910-009-0010-0&token2=exp=1455166184~acl=%2Fstatic%2Fpdf%2F930%2Fart%25253A10.1007
de Lucía N, Pio Ausiello F, Spisto M, Manganelli F, Salvatore E, Dubbioso R. The emotional impact of COVID-19 outbreak in amyotrophic lateral sclerosis patients: evaluation of depression, anxiety and interoceptive awareness. Neurological Sciences. 2020;41:2339–41.
The works published in this magazine are subject to the following terms:
1. The Publications Service of the University of Murcia (the publisher) preserves the copyright of the published works, and encourages and allows the reuse of the works under the license for use stated in point 2.
© Servicio de Publicaciones, Universidad de Murcia, 2011 (© Publications Service, University of Murcia, 2011)
2. The works are published in the electronic edition of the journal under Creative Commons Reconocimiento-NoComercial-SinObraDerivada 3.0 España(texto legal) “ a Attribution-NonCommercial-NoDerivatives 3.0 Spain license (legal text)”. They can be copied, used, broadcasted, transmitted and publicly displayed, provided that: i) the authorship and original source of their publication (journal, publisher and URL) are cited; (ii) are not used for commercial purposes; iii) the existence and specifications of this license is mentioned.
3. Conditions of self-archiving. Authors are allowed and encouraged to electronically disseminate the pre-print (pre-reviewed ) and / or post-print (reviewed and accepted for publication) versions of their works prior to publication, as it ensures a wider circulation and dissemination which may lead to a possible increase in its mention and a higher scope among the academic community. RoMEO color: green.
